Emergent signs $174 million deal to make AstraZeneca’s potential COVID-19 vaccine

Published 6y ago

(Reuters) – Emergent BioSolutions Inc said on Monday it signed a $174 million agreement with AstraZeneca to develop and manufacture the British drugmaker’s COVID-19 vaccine candidate. AstraZeneca in June picked Emergent to help produce 300 million doses of its... More »